Taubman Emerging Scholar Kanakadurga Singer, MD, has been designated as the inaugural Valerie Castle Opipari, MD Professor at Michigan Medicine. This new professorship honors Dr. Opipari, a pediatric oncologist-hematologist and the first woman chair of Michigan Medicine’s Department of Pediatrics, a post she held from 2003-2018. As a physician-researcher, Dr. Opipari also is a founding…
Early in the wake of the pandemic as new epidemiological data were emerging, a major concern shared by healthcare workers (HCWs) was the potential to transmit virus without any warning signs. A critical unaddressed issue is whether early detection, especially of infection before obvious symptoms, can prevent “pre-symptomatic transmission” and stop further spread. Sung…
A team of University of Michigan physician-researchers have launched a clinical trial of a drug they believe may address the deadly blood clots that form in some patients with COVID-19. The trial is the first COVID-related investigation to be initiated by Michigan Medicine scientists. The trial is based on the results of a blood inflammation…
A Michigan Medicine physician-investigator and recipient of a Taubman Institute Innovation Projects (TIIP) grant will use samples from COVID-19 patients to study how the virus affects a patient’s immune profile. Daniel Goldstein, MD, last year began a TIIP study that will scrutinize the immune system of organ transplant patients in an effort to refine the…
By Ian Demsky Senior Writer, U-M Rogel Cancer Center How do a couple of universally expressed proteins in stem cells and developing embryos influence an individual cell’s ultimate fate — whether it ultimately becomes, for example, a retinal cell, a heart muscle cell, or a stomach lining cell? That’s the question that Rajesh C.…
The Taubman Institute will co-sponsor a new DNA sequencing project that aims to expand knowledge of the human genome and its role in disease. “Short Tandem Repeats in Precision Health and Human Disease” will be jointly supported by the institute and the Michigan Medicine Precision Health research initiative. The project is one of seven funded…
The 2019 Taubman Prize Symposium featured a keynote by prize recipient Professor Sir Stephen O’Rahilly, MD, of the University of Cambridge. Dr. O’Rahilly, an endocrinologist and researcher, spoke on “The Causes and Consequences of Human Obesity.” He accepted the award from Gayle Taubman Kalisman, PhD.
Their genius. Your generosity. The Taubman Institute extends its heartfelt appreciation to all of the donors who generously contributed to our Emerging Scholars on December 3, Giving Blueday. The laboratories of five researchers will receive your gifts in early January, helping them to further investigations into depression, autoimmune disorders, cancer, dementia and more. Thank you…
Improving outcomes for patients with aggressive brain tumors is the focus of the latest U-M faculty member to be named a Taubman Emerging Scholar. Daniel R. Wahl, MD, PhD, is an assistant professor in the department of Radiation Oncology. Dr. Wahl and his research team believe that targeting metabolic abnormalities may be the key to…
A physician-researcher studying life-threatening infections is the latest U-M faculty member to be named a Taubman Emerging Scholar. Scott Van Epps, MD, PhD, is an assistant professor in Emergency Medicine, Biomedical Engineering, and Macromolecular Science and Engineering. He also serves as an investigator for the Biointerfaces Institute and an associate director at the Michigan Center…